UNC Center for AIDS Research

UNC Center for AIDS Research A research center with a fierce commitment to creating and translating knowledge that advances the f

Join us for the March CFAR-Wide Webinar, "Advancing the Mission: Future Directions for NIH HIV Research," with Dr. Geri ...
02/26/2026

Join us for the March CFAR-Wide Webinar, "Advancing the Mission: Future Directions for NIH HIV Research," with Dr. Geri Donenberg, the Associate Director for AIDS Research and Director of the Office of AIDS Research (OAR) at the National Institutes of Health (NIH). The webinar will be on March 23rd from 3:30-4:30 pm ET via Zoom. Learn more and register here: https://tinyurl.com/y48h4m88

Early registration for AIDS 2026 ends today, February 12. The Conference will take place July 26-31, 2026 in Rio de Jane...
02/12/2026

Early registration for AIDS 2026 ends today, February 12. The Conference will take place July 26-31, 2026 in Rio de Janeiro, Brazil and virtually. This year’s theme will be Rethink. Rebuild. Rise. At a pivotal moment for HIV research and response—marked by unprecedented funding cuts and disruptions to HIV programs—the world’s largest HIV/AIDS conference will convene people living with HIV, researchers, policymakers, healthcare professionals, funders, media, and community representatives.

Learn more about early registration here: https://tinyurl.com/2v75aan4

Read more about the conference here: https://tinyurl.com/2jrwk6em

Join the UNC CFAR and the NIH in honoring National Black HIV/AIDS Awareness Day on February 7th! Since 1999, this day ha...
02/05/2026

Join the UNC CFAR and the NIH in honoring National Black HIV/AIDS Awareness Day on February 7th! Since 1999, this day has highlighted the importance of community engagement and improved access to HIV education, prevention, testing, and treatment services. While progress have been made in the areas of prevention, care, and treatment, HIV/AIDS continues to disproportionately impact Black and African American individuals. This day raises awareness of the continued work that is needed to improve access to prevention and care and reduce health disparities related to HIV. Use the hashtag on social media to learn more and honor the day.

Read more here: https://www.med.unc.edu/cfar/2026/02/the-unc-cfar-honors-national-black-hiv-aids-awareness-day/

The Respond Carolinas project is working to strengthen HIV prevention and care in Charlotte, NC and the surrounding area...
01/29/2026

The Respond Carolinas project is working to strengthen HIV prevention and care in Charlotte, NC and the surrounding area through implementing an enhanced version of the CDC's Social Network Strategy! The project is led by Ann Dennis, MD, MS, the principal investigator and an associate professor of infectious diseases at UNC; Meagan Zarwell, PhD, the co‑investigator and an associate professor of epidemiology and community health at UNC Charlotte; and other experts at UNC and UNCC. Read more here: https://www.med.unc.edu/cfar/2026/01/respond-carolinas-is-strengthening-hiv-prevention-and-care/

A new study, published in Annals of Internal Medicine and led by Joe Eron, MD, Director of the CFAR Clinical Core, found...
01/22/2026

A new study, published in Annals of Internal Medicine and led by Joe Eron, MD, Director of the CFAR Clinical Core, found that a new once-weekly oral HIV treatment regimen of islatravir plus lenacapavir (ISL + LEN) achieved virologic suppression through 48 weeks. These findings suggest that a once-weekly oral HIV treatment regimen could help reduce barriers associated with adhering to a daily pill for people living with HIV. Dr. Joe Eron discussed, “People living with HIV deserve options that work not only medically, but practically. Daily pills are effective, but they’re not the right fit for everyone. Seeing such strong suppression with a once‑weekly regimen is incredibly encouraging. It suggests we may be able to offer patients a simpler approach that still delivers the control they need.”

Read more here: https://www.med.unc.edu/cfar/2026/01/new-once-weekly-hiv-oral-regimen-shows-strong-results-after-48-weeks/

The AIDS Clinical Trials Group (ACTG) has begun the IPACE-HIV study (Improving Physical Ability and Cellular Senescence ...
01/15/2026

The AIDS Clinical Trials Group (ACTG) has begun the IPACE-HIV study (Improving Physical Ability and Cellular Senescence Elimination in HIV). IPACE-HIV aims to evaluate the safety, tolerability, and efficacy of dasatinib and quercetin, medications that can help with reversing symptoms of frailty, in people living with HIV (PLWH), as well as their impact on physical function outcomes.

As Dr. Eron at UNC discussed, “ACTG is excited to undertake the first carefully controlled study evaluating senolytics as a potential intervention against frailty among people living with HIV. This approach is exciting because it focuses on altering what may be the underlying cause of age-related conditions instead of the conditions themselves.” Read more here: https://www.med.unc.edu/cfar/2026/01/actg-launches-ipace-hiv-to-study-frailty-intervention/

UNC CFAR SBIS Core Director Vivian Go and Developmental Core Co-Director Bill Miller, along with their research team, re...
01/08/2026

UNC CFAR SBIS Core Director Vivian Go and Developmental Core Co-Director Bill Miller, along with their research team, recently published the findings from their implementation trial in ten provinces in Vietnam. The study aimed to compare two approaches to implementing the SNaP intervention: a “one-size-fits-all” approach and a tailored approach.

The results showed that using a tailored and locally informed approach to implement SNaP increased fidelity, compared to the “one-size-fits-all” method. Additionally, individuals who received the tailored SNaP approach had greater levels of viral suppression than those who received the standard version. Among both approaches, almost all participants initiated ART. These findings highlight the importance of using locally informed strategies when implementing evidence-based interventions related to HIV care and prevention for individuals who inject drugs.

Read more here: https://tinyurl.com/4bbavctr and https://www.med.unc.edu/cfar/2026/01/landmark-findings-from-study-on-a-tailored-implementation-approach-improves-hiv-intervention-for-people-who-inject-drugs-in-vietnam/

Congratulations to the UNC Institute for Global Health and Infectious Diseases for being awarded an ID STEP (Infectious ...
12/18/2025

Congratulations to the UNC Institute for Global Health and Infectious Diseases for being awarded an ID STEP (Infectious Disease Structured Training and Engagement Program) grant! This grant will be used to develop a program for medical students to expand equitable access to infectious disease expertise for folks living in North Carolina, particularly in rural and underserved areas. The program will be led by Jessica Lin, MD, MSCR, and Brian Bramson, MD, and supported by Sarah Rutstein, MD, PhD and Christopher Sellers, MD, MPH. Read more here: https://www.med.unc.edu/cfar/2025/12/id-step-grant-award-will-build-north-carolinas-pipeline-of-infectious-disease-specialists/

The UNC CFAR congratulates the Malawi HIV Implementation Research Scientist Training (M-HIRST) program for its recent re...
11/20/2025

The UNC CFAR congratulates the Malawi HIV Implementation Research Scientist Training (M-HIRST) program for its recent renewal with partners at Kamuzu University of Health Sciences! The M-HIRST program will continue to strengthen Malawi’s capacity for mentored HIV and implementation research training. To date, 89 trainees have benefited from the program, creating a growing cohort of researchers in Malawi. Read more about the M-HIRST program and its renewal here: med.unc.edu/cfar/2025/11/m-hirst-grant-renewal-demonstrates-growth-and-leadership/

We’re proud to share that CFAR member Sarah Rutstein, MD, PhD, has received a multi-year NIH R34 grant to pilot field-ba...
11/05/2025

We’re proud to share that CFAR member Sarah Rutstein, MD, PhD, has received a multi-year NIH R34 grant to pilot field-based HIV care delivery across North Carolina. Her research will focus on reaching people with HIV who are out of care—bringing treatment directly to communities and exploring the use of long-acting injectable ART, administered every two months instead of daily pills. This groundbreaking study will help shape future strategies to improve care access and viral suppression across the state. To read more about Dr. Rutstein’s work, click here; https://www.med.unc.edu/cfar/2025/11/cfar-member-sarah-rutstein-receives-multi-year-nih-grant-to-study-field-based-hiv-care-delivery-in-north-carolina/

Join us for Medicine Grand Rounds on Thursday, Oct 30, 12–1 PM! Dr. David Wohl presents: “How Internists Will End the U....
10/29/2025

Join us for Medicine Grand Rounds on Thursday, Oct 30, 12–1 PM! Dr. David Wohl presents: “How Internists Will End the U.S. HIV Epidemic.” Attend in person (Old Clinic Building Auditorium, 4th Floor) or virtually.

During University Research Week, the Institute for Global Health and Infectious Diseases brought together leading resear...
10/28/2025

During University Research Week, the Institute for Global Health and Infectious Diseases brought together leading researchers and the Center for AIDS Research leadership — including Drs. Sonia Napravnik, David Wohl, Ross Boyce, Vivian Go, and Sarah Rutstein — to discuss infectious disease threats, climate change, overdose crises, and system-level solutions. To read more about this discussion, click here to read the full summary of the discussion; https://www.med.unc.edu/cfar/2025/10/exploring-the-links-between-global-health-and-local-action/

Address

Chapel Hill, NC
27599

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+19199661558

Alerts

Be the first to know and let us send you an email when UNC Center for AIDS Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UNC Center for AIDS Research:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram